This post is an authorized copy of a press release and was not written by LegalReader.




Lex Machina’s Fifth Annual Patent Litigation Year in Review

Our friends at Lex Machina, recently released the company’s fifth annual Patent Litigation Year in Review report. This report is a wealth of information for those practicing patent law. Below is the company’s announcement and a preview of the helpful information found in the report.




Lex Machina Releases End-of-Year Litigation Trends Update

I’m pleased to say that Legal Analytics provider Lex Machina announced the release its end of year quarterly litigation trends update. The update includes Q42017 trends in the areas of Patent, Patent Trial & Appeal Board (PTAB), Copyright, Trademark, Securities, Antitrust, Commercial, Employment, Bankruptcy Appeals, and Product Liability litigation. This is a valuable source of information for any litigator. That announcement, and excerpts from the report, are reproduced below, courtesy of the company.




Holly Dolejsi of Robins Kaplan Appointed Farxiga MDL Co-Lead Counsel

We’re pleased to share the news that “Judge Lorna G. Schofield of the U.S. District Court for the Southern District of New York has appointed Robins Kaplan LLP® attorney Holly Dolejsi as co-lead counsel in multidistrict litigation (MDL) involving the diabetes drug Farxiga. Dolejsi will also serve as one of seven attorneys on the Plaintiffs’ Steering Committee